ID   GSDME_HORSE             Reviewed;         497 AA.
AC   Q7YS54;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   10-FEB-2021, entry version 59.
DE   RecName: Full=Gasdermin-E {ECO:0000250|UniProtKB:O60443};
DE   AltName: Full=Non-syndromic hearing impairment protein 5 homolog {ECO:0000305};
DE   Contains:
DE     RecName: Full=Gasdermin-E, N-terminal {ECO:0000250|UniProtKB:O60443};
DE              Short=GSDME-NT {ECO:0000250|UniProtKB:O60443};
DE   Contains:
DE     RecName: Full=Gasdermin-E, C-terminal {ECO:0000250|UniProtKB:O60443};
DE              Short=GSDME-CT {ECO:0000250|UniProtKB:O60443};
GN   Name=GSDME {ECO:0000250|UniProtKB:O60443};
GN   Synonyms=DFNA5 {ECO:0000250|UniProtKB:O60443};
OS   Equus caballus (Horse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus.
OX   NCBI_TaxID=9796;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=12853124; DOI=10.1016/s0925-4439(03)00083-8;
RA   Gregan J., Van Laer L., Lieto L.D., Van Camp G., Kearsey S.E.;
RT   "A yeast model for the study of human DFNA5, a gene mutated in nonsyndromic
RT   hearing impairment.";
RL   Biochim. Biophys. Acta 1638:179-186(2003).
CC   -!- FUNCTION: [Gasdermin-E]: Precursor of a pore-forming protein that
CC       converts non-inflammatory apoptosis to pyroptosis. This form
CC       constitutes the precursor of the pore-forming protein: upon cleavage,
CC       the released N-terminal moiety (Gasdermin-E, N-terminal) binds to
CC       membranes and forms pores, triggering pyroptosis.
CC       {ECO:0000250|UniProtKB:O60443}.
CC   -!- FUNCTION: [Gasdermin-E, N-terminal]: Pore-forming protein produced by
CC       cleavage by CASP3 or granzyme B (GZMB), which converts non-inflammatory
CC       apoptosis to pyroptosis or promotes granzyme-mediated pyroptosis,
CC       respectively. After cleavage, moves to the plasma membrane,
CC       homooligomerizes within the membrane and forms pores of 10-15
CC       nanometers (nm) of inner diameter, triggering pyroptosis. Binds to
CC       inner leaflet lipids, bisphosphorylated phosphatidylinositols, such as
CC       phosphatidylinositol (4,5)-bisphosphate. Cleavage by CASP3 switches
CC       CASP3-mediated apoptosis induced by TNF or danger signals, such as
CC       chemotherapy drugs, to pyroptosis. Mediates secondary necrosis
CC       downstream of the mitochondrial apoptotic pathway and CASP3 activation
CC       as well as in response to viral agents. Exhibits bactericidal activity.
CC       Cleavage by GZMB promotes tumor suppressor activity by triggering
CC       robust anti-tumor immunity. Suppresses tumors by mediating granzyme-
CC       mediated pyroptosis in target cells of natural killer (NK) cells:
CC       cleavage by granzyme B (GZMB), delivered to target cells from NK-cells,
CC       triggers pyroptosis of tumor cells and tumor suppression. May play a
CC       role in the p53/TP53-regulated cellular response to DNA damage.
CC       {ECO:0000250|UniProtKB:O60443}.
CC   -!- ACTIVITY REGULATION: [Gasdermin-E]: The full-length protein before
CC       cleavage is inactive: intramolecular interactions between N- and C-
CC       terminal domains mediate autoinhibition in the absence of activation
CC       signal. The intrinsic pyroptosis-inducing activity is carried by the
CC       released N-terminal moiety (Gasdermin-E, N-terminal) following cleavage
CC       by CASP3 or granzyme B (GZMB). {ECO:0000250|UniProtKB:O60443}.
CC   -!- SUBUNIT: [Gasdermin-E, N-terminal]: Homooligomer; homooligomeric ring-
CC       shaped pore complex containing 27-28 subunits when inserted in the
CC       membrane. {ECO:0000250|UniProtKB:Q5Y4Y6}.
CC   -!- SUBCELLULAR LOCATION: [Gasdermin-E, N-terminal]: Cell membrane
CC       {ECO:0000250|UniProtKB:O60443}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q5Y4Y6}.
CC   -!- SUBCELLULAR LOCATION: [Gasdermin-E]: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:O60443}.
CC   -!- DOMAIN: Intramolecular interactions between N- and C-terminal domains
CC       may be important for autoinhibition in the absence of activation
CC       signal. The intrinsic pyroptosis-inducing activity is carried by the N-
CC       terminal domain, that is released upon cleavage by CASP3 or granzyme B
CC       (GZMB). {ECO:0000250|UniProtKB:O60443}.
CC   -!- PTM: Cleavage at Asp-270 by CASP3 (mature and uncleaved precursor
CC       forms) or granzyme B (GZMB) relieves autoinhibition and is sufficient
CC       to initiate pyroptosis. {ECO:0000250|UniProtKB:O60443}.
CC   -!- PTM: [Gasdermin-E]: Succination by the Krebs cycle intermediate
CC       fumarate, which leads to S-(2-succinyl)cysteine residues, inhibits
CC       processing by caspases, and ability to initiate pyroptosis. Succination
CC       modification is catalyzed by a non-enzymatic reaction caused by an
CC       accumulation of fumarate. {ECO:0000250|UniProtKB:O60443}.
CC   -!- SIMILARITY: Belongs to the gasdermin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY194290; AAP35046.1; -; mRNA.
DR   RefSeq; NP_001075358.1; NM_001081889.1.
DR   SMR; Q7YS54; -.
DR   PaxDb; Q7YS54; -.
DR   GeneID; 100033992; -.
DR   KEGG; ecb:100033992; -.
DR   CTD; 1687; -.
DR   InParanoid; Q7YS54; -.
DR   OrthoDB; 1397132at2759; -.
DR   Proteomes; UP000002281; Unplaced.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:1901612; F:cardiolipin binding; ISS:UniProtKB.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0022829; F:wide pore channel activity; ISS:UniProtKB.
DR   GO; GO:0008219; P:cell death; ISS:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB.
DR   GO; GO:0098586; P:cellular response to virus; ISS:UniProtKB.
DR   GO; GO:0140507; P:granzyme-mediated programmed cell death signaling pathway; ISS:UniProtKB.
DR   GO; GO:0070265; P:necrotic cell death; ISS:UniProtKB.
DR   GO; GO:0002839; P:positive regulation of immune response to tumor cell; ISS:UniProtKB.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; ISS:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0070269; P:pyroptosis; ISS:UniProtKB.
DR   InterPro; IPR040460; Gasdermin_pore.
DR   InterPro; IPR041263; Gasdermin_PUB.
DR   InterPro; IPR042377; GSDME.
DR   PANTHER; PTHR15207; PTHR15207; 1.
DR   Pfam; PF04598; Gasdermin; 1.
DR   Pfam; PF17708; Gasdermin_C; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Cytoplasm; Membrane; Necrosis; Reference proteome;
KW   Transmembrane; Transmembrane beta strand.
FT   CHAIN           1..497
FT                   /note="Gasdermin-E"
FT                   /id="PRO_0000148177"
FT   CHAIN           1..270
FT                   /note="Gasdermin-E, N-terminal"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
FT                   /id="PRO_0000442747"
FT   CHAIN           271..497
FT                   /note="Gasdermin-E, C-terminal"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
FT                   /id="PRO_0000442748"
FT   REGION          1..56
FT                   /note="Membrane targeting domain"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
FT   SITE            270..271
FT                   /note="Cleavage; by CASP3 or granzyme B"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
FT   MOD_RES         45
FT                   /note="S-(2-succinyl)cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
FT   MOD_RES         156
FT                   /note="S-(2-succinyl)cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
FT   MOD_RES         168
FT                   /note="S-(2-succinyl)cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
FT   MOD_RES         180
FT                   /note="S-(2-succinyl)cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
FT   MOD_RES         235
FT                   /note="S-(2-succinyl)cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
FT   MOD_RES         371
FT                   /note="S-(2-succinyl)cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
FT   MOD_RES         409
FT                   /note="S-(2-succinyl)cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
FT   MOD_RES         418
FT                   /note="S-(2-succinyl)cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
FT   MOD_RES         491
FT                   /note="S-(2-succinyl)cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:O60443"
SQ   SEQUENCE   497 AA;  54883 MW;  229FAA7C7770D369 CRC64;
     MFAKATRSFL REVDAEGDLI AVSNLNDSDK SQLLSLVTKK KRFWCWQRPK YQFLSVTLGD
     VLTEAQCLSP VVVESDFVKY EGKFENHVSG TIETALGKVK LNFGDKGLRE SQSSFGTLRK
     QEVDLQQLIR DSVERTINLK NPVLQQMLES KNEVLCILTQ KIVTTQKCVI SEHIQTEEKC
     GGMVGIKTKT VQVSVTKDEN IIKDASVALE IPAPTTIAYS VIELYVKLDG QFEFCLLRGK
     HGGFEHQRRS DIVFPDAGAL QDFPFWDVPD AGQGLPTPDG PLSVLKQGTR LLEKNFFPFV
     ELPEQHRTAL NTVLQAVLSD EELLAVLEQV CDDLVHSLSP PLAMLGELKP PHRQDLTAFL
     RLVGYRVQGG CPCLEDGVGS QKLFSTAYFL VSALAEMPDN AAALLGTCCK LQIIPALCHL
     LHAMSHDGVC DLEDPALAPL KDTERFGVAQ RLFASADINL ERVQSSVKAV TPLKDPSVLP
     LILYISLKGL CALGREH
//
